Diagnostic and Interventional Cardiology

The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a shortage of Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) devices,

Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) Shortage - Letter to Health Care Providers

December 5, 2022 — The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a ...

December 05, 2022

Feature | Cardiovascular Business

Sponsored Content

Organizations relying on multiple cardiovascular systems might find it difficult to onboard new facilities because disparate systems don’t easily communicate with each other.

Case Study | Information Technology

Single-Database Cardiology Platform Drives Efficient Workflow and Improves Data Access

This case study from Change Healthcare presents the following: Customer: Washington Health System Washington, PA ...

January 10, 2023

Boston Scientific Corporation has announced the first results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluating the performance of the ACURATE neo2TM Aortic Valve System.

News | Structural Heart

Late-Breaking Post-Market Study Data Reinforce Clinical Procedural Success and Safety of the ACURATE neo2 Aortic Valve System

December 2, 2022 — Boston Scientific Corporation has announced the first results from the ACURATE neo2 Post Market ...

December 02, 2022

Last year, U.S. Congressman Andy Barr (KY-06) introduced this legislation in the House to honor the legacy of his wife, Carol Leavell Barr, who passed away tragically from sudden cardiac death brought on by mitral valve prolapse, an underlying heart condition that causes death in .2% of cases.

News | Heart Failure

CAROL Act Will Prioritize Research on Heart Valve Disease

December 2, 2022 — The U.S. Senate today passed the bipartisan Cardiovascular Advances in Research and Opportunities ...

December 02, 2022

Transverse heart sections from wild type mice (WT) and transgenic mice overexpressing beta-3 adrenergic receptor in cardiomyocytes (c-hB3tg) after 3 months of aortic stenosis (transaortic constriction, TAC) or control (sham). Hypertrophy after TAC was less severe in the transgenic mice. Courtesy of CNIC

News | Heart Failure

A New Therapeutic Target for the Prevention of Heart Failure Due to Aortic Stenosis

December 1, 2022 — Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have identified a new ...

December 01, 2022

Sponsored Content

Discover the key features of cardiovascular structured reporting that drive adoption, including automated data flow, EHR integration, and customizability.

Feature | Cardiac Imaging

Benefits of Cardiovascular Structured Reporting

Discover the key features of cardiovascular structured reporting that drive adoption, including automated data flow, EHR ...

November 07, 2022

Annalise.ai and Nuance announced that the global medical imaging AI company has joined the Nuance Precision Imaging Network (PIN), connecting Annalise.ai workflow orchestration and diagnostic support solutions to over 12,000 healthcare facilities worldwide.

News | ECG

HeartSciences and Rutgers University Announce Multi-Year Collaboration to Develop AI-based ECG Algorithms

December 1, 2022 — Heart Test Laboratories, Inc. d/b/a HeartSciences, a medical technology company focused on saving ...

December 01, 2022

A team led by UTHealth Houston's K. Lance Gould, MD, (center) used PET imaging technology (shown above) to map coronary blood flow and its outcomes among heart disease patients. (Photo by UTHealth Houston)

News | PET Imaging

PET Technology More Effective Than Angiogram at Determining Need for Coronary Stents, Bypass Surgery

December 1, 2022 — A new method for determining whether patients with heart disease need coronary stents or bypass ...

December 01, 2022

News | ECMO Systems

Cardiothoracic Surgeon to Lead Smidt Heart Institute's ECMO Program

November 30, 2022 — The Smidt Heart Institute at Cedars-Sinai has selected board-certified cardiothoracic surgeon Tyler ...

November 30, 2022

Sponsored Content

New procedures, new workflows, and increased collaboration across traditionally siloed areas are increasing the need for better cardiology data management tools.

Blog | Enterprise Imaging

BLOG: Capturing the Full Value of Complex Cardiology Data

The optimal delivery of cardiac care is evolving rapidly. A growing number of patients combined with innovative new ...

November 03, 2022

News | Structural Heart

Late-Breaking Post-Market Study Data Reinforce Clinical Procedural Success and Safety of the ACURATE neo2 Aortic Valve System

November 30, 2022 — Boston Scientific Corporation has announced the first results from the ACURATE neo2 Post Market ...

November 30, 2022

News | Structural Heart

Medtronic’s Next-Gen Evolut FX TAVR System Shows Significant Improvement in Commissure Alignment in Real World Setting

November 30, 2022 — Medtronic’s newest generation self-expanding, transcatheter aortic valve replacement (TAVR) system ...

November 30, 2022

News | Cardiac Imaging

AI Predicts Heart Disease Risk Using Single X-Ray

November 29, 2022 — Researchers have developed a deep learning model that uses a single chest X-ray to predict the 10 ...

November 29, 2022

Sponsored Content

Blog | Artificial Intelligence

BLOG: AI outperforms human analysis in predicting cardiac outcomes

New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...

October 10, 2022

Tanya Therapeutics announced today that the US FDA has granted orphan drug designation for its second gene therapy product candidate, TN-401, for the treatment of arrhythmogenic right ventricular cardiomyopathy (ARVC)

News | Pharmaceuticals

Tenaya Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for its Gene Therapy for Genetic Arrhythmogenic Right Ventricular Cardiomyopathy

November 28, 2022 – Tenaya Therapeutics, a clinical-stage biotechnology company with a mission to discover, develop and ...

November 28, 2022

BIOTRONIK announced their presentation of the one-year results from the investigator-initiated BIOPACT RCT this week

News | Drug-Eluting Balloons

One-Year BIOPACT Randomized Controlled Trial (RCT) Results Demonstrate Excellent Results for Low-Profile Passeo-18 Lux DCB

November 28, 2022 – BIOTRONIK announced the presentation of one-year results from the investigator-initiatedBIOPACT RCT ...

November 28, 2022

Today, UltraSight announced the findings from a landmark pivotal study that confirms its AI guidance technology enables novice ultrasound users to acquire high-quality diagnostic images of the 10 standard cardiac views.

News | Cardiac Imaging

New Landmark Study Indicates UltraSight Enables Novice Ultrasound Users to Capture High Quality Cardiac Images

November 28, 2022 – UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power ...

November 28, 2022